Product Categories
Country: | United States |
---|---|
Tel: | 781-+1-781-999-5354 |
Mobile: | +1-00000000000 |
E-mail: | info@targetmol.com |
QQ: | |
Skype: | Chat Now! |
Address: | 36 Washington Street, Wellesley Hills |
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
Product Name | MF | CAS | Details |
---|
Emapunil;AC-5216;XBD-173 | C23H23N5O2 | 226954-04-7 | Details |
Ponatinib;AP24534 | C29H27F3N6O | 943319-70-8 | Details |
Liproxstatin-1 | C19H21ClN4 | 950455-15-9 | Details |
HTH-01-015 | C26H28N8O | 1613724-42-7 | Details |
Vipadenant;BIIB-014;CEB-4520 | C16H15N7O | 442908-10-3 | Details |
BX471;ZK-811752;BX 471;BX-471 | C21H24ClFN4O3 | 217645-70-0 | Details |
Pilaralisib analogue;XL147 analogue;SAR245408 | C21H16N6O2S2 | 956958-53-5 | Details |
Vemurafenib;PLX4032;RO5185426;RG7204 | C23H18ClF2N3O3S | 918504-65-1 | Details |
Pomalidomide;CC-4047 | C13H11N3O4 | 19171-19-8 | Details |
RGB-286638 free base | C29H35N7O4 | 784210-88-4 | Details |
Panobinostat;NVP-LBH589;LBH589 | C21H23N3O2 | 404950-80-7 | Details |
BIBR 1532 | C21H17NO3 | 321674-73-1 | Details |
Abemaciclib;LY2835219;CDK4/6 dual inhibitor | C27H32F2N8 | 1231929-97-7 | Details |
UNC1215 | C32H43N5O2 | 1415800-43-9 | Details |
Ipragliflozin;ASP1941 | C21H21FO5S | 761423-87-4 | Details |
Topiroxostat;FYX-051 | C13H8N6 | 577778-58-6 | Details |
Cevimeline hydrochloride hemihydrate | C10H20ClNO2S | 153504-70-2 | Details |
Pixantrone dimaleate;BBR 2778 dimaleate;Pixantrone Maleate;BBR-2778 | C21H23N5O6 | 144675-97-8 | Details |
Pirfenidone;S-7701,AMR-69;AMR69;S-7701 | C12H11NO | 53179-13-8 | Details |
Ramatroban;BAY u3405 | C21H21FN2O4S | 116649-85-5 | Details |
Vortioxetine;Lu AA 21004 | C18H22N2S | 508233-74-7 | Details |
Efavirenz;Sustiva;Stocrin;DMP 266;EFV;L-743726 | C14H9ClF3NO2 | 154598-52-4 | Details |
Nalfurafine hydrochloride;TRK-820 hydrochloride | C28H33ClN2O5 | 152658-17-8 | Details |
Vortioxetine hydrobromide;Vortioxetine HBr;Lu AA21004 hydrobromide;Vortioxetine (Lu AA21004) HBr | C18H23BrN2S | 960203-27-4 | Details |
Glycopyrrolate;Glycopyrronium bromide;Robinul;Glycopyrrolate bromide;Gastrodyn | C19H28BrNO3- | 596-51-0 | Details |
Camostat mesylate;Camostat mesilate;FOY305;FOY-S980 | C21H26N4O8S | 59721-29-8 | Details |
Bortezomib;MG 341;DPBA;Brotezamide;NSC 681239;Radiciol;LDP 341 | C19H25BN4O4 | 179324-69-7 | Details |
Dapagliflozin;BMS-512148 | C21H25ClO6 | 461432-26-8 | Details |
Tofacitinib Citrate;Tasocitinib citrate;Tofacitinib (CP-690550) Citrate;CP-690550 citrate | C16H20N6O.C6H8O7 | 540737-29-9 | Details |
Nafamostat mesylate;FUT-175 | C21H25N5O8S2 | 82956-11-4 | Details |
Luliconazole;NND 502 | C14H9Cl2N3S2 | 187164-19-8 | Details |
BMS-794833;BMS794833 | C23H15ClF2N4O3 | 1174046-72-0 | Details |
P 22077;P22077 | C12H7F2NO3S2 | 1247819-59-5 | Details |
P7C3-A20 | C22H19Br2FN2O | 1235481-90-9 | Details |
Candesartan Cilexetil;TCV-116 | C33H34N6O6 | 145040-37-5 | Details |
SRT1720 hydrochloride;SRT1720 HCl;SRT 1720 Hydrochloride | C25H24ClN7OS | 1001645-58-4 | Details |
Vonoprazan fumarate;TAK-438 | C21H20FN3O6S | 1260141-27-2 | Details |
TG6-10-1 | C23H23F3N2O4 | 1415716-58-3 | Details |
PP121 | C17H17N7 | 1092788-83-4 | Details |
A66 | C17H23N5O2S2 | 1166227-08-2 | Details |
Nedaplatin;NSC 375101D | C2H6N2O3Pt | 95734-82-0 | Details |
BIX02189 | C27H28N4O2 | 1094614-85-3 | Details |
Alogliptin Benzoate;Alogliptin(SYR-322)benzoate;SYR 322 | C25H27N5O4 | 850649-62-6 | Details |
FH535 | C13H10Cl2N2O4S | 108409-83-2 | Details |
PHT-427;PHT 427;CS-0223;PHT427 | C20H31N3O2S2 | 1191951-57-1 | Details |
PNU-282987;PNU 282987 | C14H17ClN2O | 123464-89-1 | Details |
Cinacalcet hydrochloride;AMG-073 HCl;AMG-073 hydrochloride;Cinacalcet;Cinacalcet HCl | C22H23ClF3N | 364782-34-3 | Details |
PD 169316 | C20H13FN4O2 | 152121-53-4 | Details |
Tenofovir Disoproxil Fumarate;GS-1278 Disoproxil Fumarate;Tenofovir DF | C23H34N5O14P | 202138-50-9 | Details |
Revaprazan hydrochloride;YH1885 | C22H24ClFN4 | 178307-42-1 | Details |
Bromfenac sodium hydrate;Bromfenac sodium;Bromfenac monosodium salt sesquihydrate | C15H11BrNNaO3 | 120638-55-3 | Details |
ID-8;ID 8;ID8 | C16H14N2O4 | 147591-46-6 | Details |
EHop-016;EHop016;EHop 016 | C25H30N6O | 1380432-32-5 | Details |
Olverembatinib dimesylate;HQP1351;GZD824 Dimesylate | C31H35F3N6O7S2 | 1421783-64-3 | Details |
HPOB | C17H18N2O4 | 1429651-50-2 | Details |
NU 7026;DNA-PK Inhibitor II;LY293646;NU7026 | C17H15NO3 | 154447-35-5 | Details |
Torkinib;PP 242 | C16H16N6O | 1092351-67-1 | Details |
Sal003 | C18H15Cl4N3OS | 1164470-53-4 | Details |
Tenofovir alafenamide;GS-7340 | C21H29N6O5P | 379270-37-8 | Details |
SKLB1002 | C13H12N4O2S2 | 1225451-84-2 | Details |
Tianeptine sodium salt;Tianeptine sodium | C21H24ClN2NaO4S | 30123-17-2 | Details |
Tiagabine;Gabitril;NO050328;NO328;TGB | C20H25NO2S2 | 115103-54-3 | Details |
R406 free base;R406 (free base) | C22H23FN6O5 | 841290-80-0 | Details |
SB-505124;SB 505124;SB505124 | C20H21N3O2 | 694433-59-5 | Details |
PIK-90;PIK 90;PIK90 | C18H17N5O3 | 677338-12-4 | Details |
CI-1040;CI1040;PD 184352;CI 1040 | C17H14ClF2IN2O2 | 212631-79-3 | Details |
D4476;D 4476;Casein Kinase I Inhibitor | C23H18N4O3 | 301836-43-1 | Details |
Dacinostat;LAQ824;NVP-LAQ824 | C22H25N3O3 | 404951-53-7 | Details |
SANT-1;SANT1;SANT 1 | C23H27N5 | 304909-07-7 | Details |
Osu03012;Osu-03012;Osu 03012;AR-12 | C26H19F3N4O | 742112-33-0 | Details |
CH-223191;CH 223191 | C19H19N5O | 301326-22-7 | Details |
CID755673 | C12H11NO3 | 521937-07-5 | Details |
HMN-214;HMN214;IVX-214 | C22H20N2O5S | 173529-46-9 | Details |
IC261;SU-5607 | C18H17NO4 | 186611-52-9 | Details |
TAS-301;TAS 301;TAS301 | C23H19NO3 | 193620-69-8 | Details |
BRL 54443;BRL54443 | C14H18N2O | 57477-39-1 | Details |
A-769662;A 769662 | C20H12N2O3S | 844499-71-4 | Details |
MDL-28170;Calpain Inhibitor III | C22H26N2O4 | 88191-84-8 | Details |
AZD7545 | C19H18ClF3N2O5S | 252017-04-2 | Details |
TP808;TP 808;TP-808 | C26H34N2O5Si | 852821-06-8 | Details |
LY 303511 | C19H18N2O2 | 154447-38-8 | Details |
KNK437;Heat Shock Protein Inhibitor I | C13H11NO4 | 218924-25-5 | Details |
NSC319726;ZMC1 | C11H14N4S | 71555-25-4 | Details |
MK-8745;MK8745 | C20H19ClFN5OS | 885325-71-3 | Details |
GSK2801 | C20H21NO4S | 1619994-68-1 | Details |
EPZ011989 | C35H51N5O4 | 1598383-40-4 | Details |
GlyH-101;GlyH 101;GlyH101 | C19H15Br2N3O3 | 328541-79-3 | Details |
C646 | C24H19N3O6 | 328968-36-1 | Details |
FG-2216;FG 2216;YM-311;FG2216 | C12H9ClN2O4 | 223387-75-5 | Details |
KI8751 | C24H18F3N3O4 | 228559-41-9 | Details |
PF-562271;PF562271;PF 562271 | C21H20F3N7O3S | 717907-75-0 | Details |
PLX-4720;PLX4720 | C17H14ClF2N3O3S | 918505-84-7 | Details |
ML141;CID-2950007 | C22H21N3O3S | 71203-35-5 | Details |
PFK-015;PFK15;PFK 015;PFK015 | C17H12N2O | 4382-63-2 | Details |
IRAK-1-4 Inhibitor I;IRAK-1/4 Inhibitor I;IRAK-1/4 Inhibitor | C20H21N5O4 | 509093-47-4 | Details |
Tivozanib;AV-951;KRN951 | C22H19ClN4O5 | 475108-18-0 | Details |
CGI-1746;CGI1746 | C34H37N5O4 | 910232-84-7 | Details |
O4I1 | C16H15NO2 | 175135-47-4 | Details |
CPI203;CPI 203;CPI-203 | C19H18ClN5OS | 202591-23-9 | Details |
O4I2 | C12H11ClN2O2S | 165682-93-9 | Details |
Product Total: Product Page: | ||||
87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 |